Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). At Novo Nordisk, we are driving change to defeat Hemophilia , diabetes and other serious chronic diseases.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in Hemophilia and diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: hemophilia, growth disorders and obesity.
The company makes several drugs under various brand names, including, NovoSeven®, NovoEight® , NovoThirteen® , Refixia® , Esperoct® Tresiba®, NovoRapid®, Saxenda® , Ozempic®, Xultophy® , Ryzodeg® , NordiLet® and Victoza®.